β -Oxidation in human alcoholic and non-alcoholic hepatic steatosis

Clinical Science

Volumn 90, Issue 4, 1996, Pages 307-313

  Eaton, S ^a,b,d   Zaitoun, A M ^c   Record, C O ^a   Bartlett, K ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c MAYDAY UNIVERSITY HOSPITAL   (United Kingdom)

^d ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

3 hydroxyacyl CoA dehydrogenases; Alcoholic; Fatty liver; oxidation

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; CARNITINE DERIVATIVE; COENZYME A; ESTER; PALMITIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TRIACYLGLYCEROL; UBIQUINONE;

ALCOHOL LIVER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID OXIDATION; FATTY LIVER; HUMAN; LIVER BIOPSY; LIVER MITOCHONDRION; PRIORITY JOURNAL;

3-HYDROXYACYL COA DEHYDROGENASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENOYL-COA HYDRATASE; FATTY LIVER; FATTY LIVER, ALCOHOLIC; HUMANS; MITOCHONDRIA, LIVER; OXIDATION-REDUCTION; PALMITATES;

EID: 0029917768     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0900307     Document Type: Article

References (41)

1. Day CP, James OF, Brown AStJ, Bennett MK, Fleming IN, Yeaman SJ. The activity of the metabolic form of hepatic phosphatidate phosphohydrolase correlates with the severity of alcoholic fatty liver in human beings. Hepatology 1993; 18: 832-8.
2. 14C] and its inhibiton by alcohol in man. Life Sci 1973; 13: 113-23.
3. Blomstrand R, Kager L, Lantto O. Studies on the ethanol-induced decrease of fatty acid oxidation in rat and human liver slices. Life Sci 1973; 13: 1131-41.
4. Rabinowitz JL, Staeffen J, Hall CL, Brand JG. A probable defect in the β-oxidation of lipids in rats fed alcohol for 6 months. Alcohol 1991; 8: 241-6.
5. Grunnet N, Kondrup J. The effect of ethanol on the β-oxidation of fatty acids. Alcohol Clin Exp Res 1986; 10: 64-8S.
6. Williamson JR, Scholz R, Browning ET, Thurman RG, Fukami MH. Metabolic effects of ethanol in perfused rat liver J Biol Chem 1969; 244: 5044-54.
7. Ryle PR, Chakraborty J, Thomson AD. The effect of methylene blue on the hepatocellular redox state and liver lipid content during chronic ethanol feeding in the rat. Biochem J 1985; 232: 877-82.
8. Salaspuro MP, Shaw S, Jayatilleke E, Ross WA, Lieber CS. Attenuation of the ethanol-induced hepatic redox change after chronic alcohol consumption in baboons: metabolic consequences in vivo and in vitro. Hepatology 1981; 1: 33-8.
9. Leung NWY, Peters TJ. Palmitic acid oxidation and incorporation into triglyceride by needle liver biopsy specimens from control subjects and patients with alcoholic fatty liver disease. Clin Sci 1986; 71: 253-60.
10. Eaton S, Record CO, Bartlett K. Investigation of β-oxidation in human liver biopsies. Clin Chim Acta 1993; 220: 219-24.
11. Thorpe C. A method for the preparation of 3-ketoacyl-CoA derivatives. Anal Biochem 1986; 155: 391-4.
12. Eaton S, Turnbull DM, Bartlett K. Production of 3-enoyl-CoA esters from palmitate by rat liver mitochondria. Biochem Soc Trans 1994; 22: 119S.
13. Ogilvie I, Pourfarzam M, Jackson S, Stockdale C, Bartlett K, Turnbull DM. Very long-chain acyl-CoA dehydrogenase deficiency presenting with exercise-induced myoglobinuria. Neurology 1994; 44: 467-73.
14. Kler RS, Jackson S, Bartlett K, et al. Quantitation of acyl-CoA and acylcarnitine esters accumulated during abnormal mitochondrial fatty acid oxidation. J Biol Chem 1991; 246: 22932-8.
15. Pourfarzam M, Schaefer J, Turnbull DM, Bartlett K. Analysis of fatty acid oxidation intermediates in cultured fibroblasts: a new approach for detection of mitochondrial oxidation disorders. Clin Chem 1994; 40: 2267-75
16. Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977; 83: 346-56.
17. Shepherd D, Garland PB. Citrate synthase from rat liver. Methods Enzymol 1969; 13: 11-16.
18. El-Fakhri M, Middleton B. The existence of an inner-membrane-bound, long acyl-chain-specific 3-hydroxyacyl-CoA dehydrogenase in mammalian mitochondria. Biochim Biophys Acta 1982; 713: 270-9.
19. Jackson S, Bartlett K, Land J, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Pediatr Res 1991; 29: 406-11.
20. Stanley KK, Tubbs PK. The role of intermediates in mitochondrial fatty acid oxidation. Biochem J 1975; 150: 77-88.
21. 14C]hexadecanoyl-carnitine. Biochem J 1993; 289: 161-8.
22. Eaton S, Turnbull DM, Bartlett K. Redox control of β-oxidation in rat liver mitochondria. Eur J Biochem 1994; 220: 671-81.
23. Jackson S, Kler RS, Bartlett K, et al. Combined enzyme defect of mitochondrial fatty acid oxidation. J Clin Invest 1992; 90: 1219-25.
24. Watmough NJ, Bindoff LA, Birch-Machin MA, et al. Impaired mitochondrial β-oxidation in a patient with an abnormality of the respiratory chain. Studies in skeletal muscle mitochondria. J Clin Invest 1990; 85: 177-84
25. 14C]hexadecanoate oxidation by intact rat liver mitochondria. Biochem J 1989; 262: 261-9.
26. Sims HF, Brackett JC, Powell CK, et al. The molecular-basis of pediatric long-chain 3-hydroxyacyl-CoA dehydrogenase-deficiency associated with maternal acute fatty liver of pregnancy. Proc Natl Acad Sci USA 1995, 92: 841-5.
27. Kukielka E, Dicker E, Cederbaum Al. Increased production of reactive oxygen species by rat liver mitochondria after chronic ethanol treatment. Arch Biochem Biophys 1994; 309: 377-86.
28. Bernstein JD, Penniall R. Effects of chronic ethanol treatment upon rat liver mitochondria. Biochem Pharmacol 1978; 27: 2337-42.
29. Thayer WS, Rubin E. Molecular alterations in the respiratory chain of rat liver after chronic ethanol consumption. J Biol Chem 1981; 256: 6090-7.
30. Bianchi GP, Fiorella PL, Bargossi AM, Grossi G, Marchesini G. Reduced ubiquinone plasma levels in patients with liver cirrhosis and in chronic alcoholics. Liver 1994; 14: 138-40.
31. Ogasahara S, Engel AG, Frens D, Mack D. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci USA 1989; 86: 2379-82.
32. Kiessling KH, Pilstrom L, Strandberg B, Lindgren L. Ethanol and the human liver. Correlation between mitochondrial size and degree of ethanol abuse. Acta Med Scand 1965; 178: 533-5.
33. Cederbaum AI, Lieber CS, Rubin E. Effects of chronic ethanol treatment on mitochondrial functions: damage to coupling site I. Arch Biochem Biophys 1974; 165: 560-9.
34. Arai M, Leo MA, Nakano M, Gordon ER, Lieber CS. Biochemical and morphological alterations of baboon hepatic mitochondria alter chronic ethanol consumption. Hepatology 1984; 4: 165-74.
35. Coleman WB, Cunningham CC. Effects of chronic ethanol consumption on the synthesis of polypeptides encoded by the hepatic mitochondrial genome. Biochim Biophys Acta 1990; 1019: 142-50.
36. Jenkins WJ, Peters TJ. Mitochondrial enzyme activities in liver biopsies from patients with alcoholic liver disease. Gut 1978; 19: 341-4.
37. Fromenty B, Grimbert S, Mansouri A, et al. Hepatic mitochondrial DNA deletion in alcoholics: association with microvesicular steatosis. Gastroenterology 1995; 108: 193-200.
38. Latipää PM, Karki TT, Hiltunen JK, Hassinen IE. Regulation of palmitoylcarnitine oxidation in isolated rat liver mitochondria. Role of the redox state of NAD(H). Biochim Biophys Acta 1986; 875: 293-300.
39. Seligson D, Waldstein SS, Giges B, Meroney WH, Sborov VM. Some metabolic effects of alcohol in humans. Clin Res 1953; 1: 86.
40. Lieber CS. Effects of ethanol upon lipid metabolism. Lipids 1974; 9: 103-16.
41. Simpson KJ, Venkatesan S, Smith GD, Peters TJ. Very-low-density lipoprotein-triacylglycerol (VLDL-TG) turnover in alcoholic subjects. Biochem Soc Trans 1990; 18: 1189-91.